Skip to main content
Clinical Trials/NCT01272024
NCT01272024
Completed
Phase 3

An Intervention to Improve Outcomes in Patients With Advanced Cancer

Yale University1 site in 1 country146 target enrollmentSeptember 2009
ConditionsCancer

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Cancer
Sponsor
Yale University
Enrollment
146
Locations
1
Primary Endpoint
Uncertainty
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of patients from surgery/biopsy/chemotherapy to medical oncology in a comprehensive cancer center.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
August 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • primary diagnosis of advanced lung, GI, Head \& Neck, and Lung cancers
  • post-surgical/or post-biopsy with physician's order for cancer treatment
  • age 21 years or older
  • lives within 50 of Yale New Haven Hospital
  • has 2 or more co-morbid conditions
  • has an emotional distress thermometer score of greater than or equal to 4-

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Uncertainty

Time Frame: 3 months post-baseline

The MUIS-C is a 23-item scale that asks the respondent to rate items on a scale of 1=strongly disagree to 5= strongly agree.

Secondary Outcomes

  • HADS- Anxiety(1 month post baseline)
  • HADS-Anxiety(3 months post baseline.)

Study Sites (1)

Loading locations...

Similar Trials